Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Verdezyne Groundbreaking Ceremony in Malaysia Commemorates Initiation Of The World's First Biobased DDDA Plant

Verdezyne
Posted on: 31 Jul 17

CARLSBAD, Calif. and KUALA LUMPUR, Malaysia, July 30, 2017 /PRNewswire/ -- Verdezyne Inc., a synthetic biology company producing biobased chemicals, announced today that a groundbreaking ceremony was held on July 30th for its VerdePalm plant, Verdezyne's first commercial-scale renewable chemicals manufacturing facility, at the Bio-XCell premier biotechnology and ecosystem park in Nusajaya, Iskandar, in southern Malaysia. The new facility is designed to produce biobased long chain diacids via fermentation of Verdezyne's proprietary yeast, which has been engineered to use non-food biomass to produce high value chemicals.  The first product produced at VerdePalm will be dodecanedioic acid (DDDA), a 12-carbon diacid that is a component of many consumer products currently made from petroleum.  DDDA is a main building block of FerroShieldTM, Verdezyne's nitrate-free dibasic acid mixture used in a variety of corrosion inhibitor applications.

The groundbreaking ceremony for the VerdePalm plant was co-hosted by Chad Waite, Chairman of the Verdezyne Board of Directors, and YBhg. Tan Sri Dato' Abdul Ghani Othman, Chairman of the Board of Sime Darby Berhad, the largest investor in Verdezyne Inc.  Attendees included Malaysian dignitaries and representatives from Verdezyne's partners, Bio-XCell Malaysia and the Malaysian Biotechnology Corporation.  The Guest of Honor, YAB Dato' Mohamed Khaled Nordin, Chief Minister of Johor, presented the Officiating Speech.

The VerdePalm plant is expected to be completed in 12-18 months.  VerdePalm will be the world's first biobased plant for DDDA production.  "Importantly, the starting yeast will be made from the spent biomass that results from palm oil processing," Waite stated.  "Crude palm oil and palm byproducts, as well as other plant-based raw materials, will be used to produce approximately 6,000 metric tons of industrial grade DDDA each year.  Verdezyne's technology will enable a very low-value by-product of palm oil processing to become a high-value "green" product that reduces the use of petroleum." 

"We are excited that a product made by Verdezyne and our Malaysian partners will be shipped around the world to be used as an alternative to the typical petroleum-derived intermediate chemicals," said E. William Radany, Ph.D., President and CEO of Verdezyne. "The VerdePalm plant is part of our comprehensive strategy of expansion into Asia, and represents a major step toward our goal of replacing petroleum-derived chemicals with renewable drop-in replacements," he noted.

"Malaysia is proud to host Verdezyne's first commercial manufacturing plant, which is located at the Malaysin Bio-XCell park.  I believe the eco-system provided by the park will be an excellent fit for the VerdePalm facility.  Malaysia will continue to commit to the ongoing advancement of biotechnology in the country.  The groundbreaking ceremony signifies Verdezyne's readiness to work with Malaysia and marks another milestone in our quest to add value to the palm industry using biotechnology as a catalyst," said Zainal Azman B. Abu Kasim, Senior Vice President of BioIndustrials, Bioeconomy Corporation in Malaysia.

DDDA is a key component of FerroShield, which can be used in numerous corrosion inhibitor applications including metalworking fluids, engine coolants, metal cleaners, die cast release agents, and aqueous hydraulic fluids.  "Marketing of FerroShield was launched in February of this year," Dr. Radany added. "The rust inhibition industry is in need of a high-performing dibasic acid mixture that can be easily incorporated into existing customer formulas.  We foresee strong demand for FerroShield in a number of countries in Asia and Europe, as well as in the U.S. and Canada."

About Verdezyne 
Verdezyne is a synthetic biology company offering biobased chemicals manufactured via fermentation of its proprietary yeast cells. The company has two commercial products, BIOLON™ DDDA (dodecanedioic acid) and FerroShield™ dibasic acid mixture.  Current investors in Verdezyne include BP Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures, and Sime Darby. For more information, visit www.verdezyne.com or connect with the company on Twitter, LinkedIn or Facebook.

For samples, orders or more information about Verdezyne's FerroShield, please contact:

The U.S.: kwilkinson@aceto.com

Asia: ddda@wecocbc.com

Europe: ferroshield@will-co.nl

Verdezyne Media Contact:

Jenna Ngian 
Vice President, Global Sales and Marketing
JNgian@Verdezyne.com  
760-707-5288 

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 31/07/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.